Global Age-Related Macular Degeneration (AMD) Therapeutics Market Research Report 2024, Forecast to 2032
Report Overview
Age-related macular degeneration is a bilateral ocular condition in which the central area of the retina, known as the macula, is affected.
The global Age-Related Macular Degeneration (AMD) Therapeutics market size was estimated at USD 7725.70 million in 2023 and is projected to reach USD 12832.43 million by 2032, exhibiting a CAGR of 5.80% during the forecast period.
North America Age-Related Macular Degeneration (AMD) Therapeutics market size was estimated at USD 2218.23 million in 2023, at a CAGR of 4.97% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Age-Related Macular Degeneration (AMD) Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Age-Related Macular Degeneration (AMD) Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Age-Related Macular Degeneration (AMD) Therapeutics market in any manner.
Global Age-Related Macular Degeneration (AMD) Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Amgen Inc.
Bausch Health Companies
Inc.
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Market Segmentation (by Type)
Wet AMD
Dry AMD
Market Segmentation (by Application)
Hospital
Clinic
Research Institute
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Age-Related Macular Degeneration (AMD) Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Age-Related Macular Degeneration (AMD) Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
Age-related macular degeneration is a bilateral ocular condition in which the central area of the retina, known as the macula, is affected.
The global Age-Related Macular Degeneration (AMD) Therapeutics market size was estimated at USD 7725.70 million in 2023 and is projected to reach USD 12832.43 million by 2032, exhibiting a CAGR of 5.80% during the forecast period.
North America Age-Related Macular Degeneration (AMD) Therapeutics market size was estimated at USD 2218.23 million in 2023, at a CAGR of 4.97% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Age-Related Macular Degeneration (AMD) Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Age-Related Macular Degeneration (AMD) Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Age-Related Macular Degeneration (AMD) Therapeutics market in any manner.
Global Age-Related Macular Degeneration (AMD) Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Amgen Inc.
Bausch Health Companies
Inc.
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Market Segmentation (by Type)
Wet AMD
Dry AMD
Market Segmentation (by Application)
Hospital
Clinic
Research Institute
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Age-Related Macular Degeneration (AMD) Therapeutics Market
- Overview of the regional outlook of the Age-Related Macular Degeneration (AMD) Therapeutics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Age-Related Macular Degeneration (AMD) Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Age-Related Macular Degeneration (AMD) Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Age-Related Macular Degeneration (AMD) Therapeutics
1.2 Key Market Segments
1.2.1 Age-Related Macular Degeneration (AMD) Therapeutics Segment by Type
1.2.2 Age-Related Macular Degeneration (AMD) Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Age-Related Macular Degeneration (AMD) Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Age-Related Macular Degeneration (AMD) Therapeutics Sales Sites, Area Served, Product Type
3.6 Age-Related Macular Degeneration (AMD) Therapeutics Market Competitive Situation and Trends
3.6.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Age-Related Macular Degeneration (AMD) Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Age-Related Macular Degeneration (AMD) Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Age-Related Macular Degeneration (AMD) Therapeutics Price by Type (2019-2024)
7 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Sales by Application (2019-2024)
7.3 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Growth Rate by Application (2019-2024)
8 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET CONSUMPTION BY REGION
8.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region
8.1.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region
8.1.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Age-Related Macular Degeneration (AMD) Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Age-Related Macular Degeneration (AMD) Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Age-Related Macular Degeneration (AMD) Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Age-Related Macular Degeneration (AMD) Therapeutics by Region (2019-2024)
9.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Region (2019-2024)
9.3 Global Age-Related Macular Degeneration (AMD) Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Age-Related Macular Degeneration (AMD) Therapeutics Production
9.4.1 North America Age-Related Macular Degeneration (AMD) Therapeutics Production Growth Rate (2019-2024)
9.4.2 North America Age-Related Macular Degeneration (AMD) Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Age-Related Macular Degeneration (AMD) Therapeutics Production
9.5.1 Europe Age-Related Macular Degeneration (AMD) Therapeutics Production Growth Rate (2019-2024)
9.5.2 Europe Age-Related Macular Degeneration (AMD) Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Age-Related Macular Degeneration (AMD) Therapeutics Production (2019-2024)
9.6.1 Japan Age-Related Macular Degeneration (AMD) Therapeutics Production Growth Rate (2019-2024)
9.6.2 Japan Age-Related Macular Degeneration (AMD) Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Age-Related Macular Degeneration (AMD) Therapeutics Production (2019-2024)
9.7.1 China Age-Related Macular Degeneration (AMD) Therapeutics Production Growth Rate (2019-2024)
9.7.2 China Age-Related Macular Degeneration (AMD) Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Amgen Inc.
10.1.1 Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Basic Information
10.1.2 Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
10.1.3 Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Market Performance
10.1.4 Amgen Inc. Business Overview
10.1.5 Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics SWOT Analysis
10.1.6 Amgen Inc. Recent Developments
10.2 Bausch Health Companies
10.2.1 Bausch Health Companies Age-Related Macular Degeneration (AMD) Therapeutics Basic Information
10.2.2 Bausch Health Companies Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
10.2.3 Bausch Health Companies Age-Related Macular Degeneration (AMD) Therapeutics Product Market Performance
10.2.4 Bausch Health Companies Business Overview
10.2.5 Bausch Health Companies Age-Related Macular Degeneration (AMD) Therapeutics SWOT Analysis
10.2.6 Bausch Health Companies Recent Developments
10.3 Inc.
10.3.1 Inc. Age-Related Macular Degeneration (AMD) Therapeutics Basic Information
10.3.2 Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
10.3.3 Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Market Performance
10.3.4 Inc. Age-Related Macular Degeneration (AMD) Therapeutics SWOT Analysis
10.3.5 Inc. Business Overview
10.3.6 Inc. Recent Developments
10.4 F. Hoffmann-La Roche Ltd.
10.4.1 F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Basic Information
10.4.2 F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
10.4.3 F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Product Market Performance
10.4.4 F. Hoffmann-La Roche Ltd. Business Overview
10.4.5 F. Hoffmann-La Roche Ltd. Recent Developments
10.5 Novartis AG
10.5.1 Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Basic Information
10.5.2 Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
10.5.3 Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Product Market Performance
10.5.4 Novartis AG Business Overview
10.5.5 Novartis AG Recent Developments
10.6 Regeneron Pharmaceuticals Inc.
10.6.1 Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Basic Information
10.6.2 Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
10.6.3 Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Market Performance
10.6.4 Regeneron Pharmaceuticals Inc. Business Overview
10.6.5 Regeneron Pharmaceuticals Inc. Recent Developments
11 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast
11.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Region
11.2.4 South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Age-Related Macular Degeneration (AMD) Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Age-Related Macular Degeneration (AMD) Therapeutics by Type (2025-2032)
12.1.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Age-Related Macular Degeneration (AMD) Therapeutics by Type (2025-2032)
12.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast by Application (2025-2032)
12.2.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) Forecast by Application
12.2.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Age-Related Macular Degeneration (AMD) Therapeutics
1.2 Key Market Segments
1.2.1 Age-Related Macular Degeneration (AMD) Therapeutics Segment by Type
1.2.2 Age-Related Macular Degeneration (AMD) Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Age-Related Macular Degeneration (AMD) Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Age-Related Macular Degeneration (AMD) Therapeutics Sales Sites, Area Served, Product Type
3.6 Age-Related Macular Degeneration (AMD) Therapeutics Market Competitive Situation and Trends
3.6.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Age-Related Macular Degeneration (AMD) Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Age-Related Macular Degeneration (AMD) Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Age-Related Macular Degeneration (AMD) Therapeutics Price by Type (2019-2024)
7 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Sales by Application (2019-2024)
7.3 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Growth Rate by Application (2019-2024)
8 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET CONSUMPTION BY REGION
8.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region
8.1.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region
8.1.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Age-Related Macular Degeneration (AMD) Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Age-Related Macular Degeneration (AMD) Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Age-Related Macular Degeneration (AMD) Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Age-Related Macular Degeneration (AMD) Therapeutics by Region (2019-2024)
9.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Region (2019-2024)
9.3 Global Age-Related Macular Degeneration (AMD) Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Age-Related Macular Degeneration (AMD) Therapeutics Production
9.4.1 North America Age-Related Macular Degeneration (AMD) Therapeutics Production Growth Rate (2019-2024)
9.4.2 North America Age-Related Macular Degeneration (AMD) Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Age-Related Macular Degeneration (AMD) Therapeutics Production
9.5.1 Europe Age-Related Macular Degeneration (AMD) Therapeutics Production Growth Rate (2019-2024)
9.5.2 Europe Age-Related Macular Degeneration (AMD) Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Age-Related Macular Degeneration (AMD) Therapeutics Production (2019-2024)
9.6.1 Japan Age-Related Macular Degeneration (AMD) Therapeutics Production Growth Rate (2019-2024)
9.6.2 Japan Age-Related Macular Degeneration (AMD) Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Age-Related Macular Degeneration (AMD) Therapeutics Production (2019-2024)
9.7.1 China Age-Related Macular Degeneration (AMD) Therapeutics Production Growth Rate (2019-2024)
9.7.2 China Age-Related Macular Degeneration (AMD) Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Amgen Inc.
10.1.1 Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Basic Information
10.1.2 Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
10.1.3 Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Market Performance
10.1.4 Amgen Inc. Business Overview
10.1.5 Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics SWOT Analysis
10.1.6 Amgen Inc. Recent Developments
10.2 Bausch Health Companies
10.2.1 Bausch Health Companies Age-Related Macular Degeneration (AMD) Therapeutics Basic Information
10.2.2 Bausch Health Companies Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
10.2.3 Bausch Health Companies Age-Related Macular Degeneration (AMD) Therapeutics Product Market Performance
10.2.4 Bausch Health Companies Business Overview
10.2.5 Bausch Health Companies Age-Related Macular Degeneration (AMD) Therapeutics SWOT Analysis
10.2.6 Bausch Health Companies Recent Developments
10.3 Inc.
10.3.1 Inc. Age-Related Macular Degeneration (AMD) Therapeutics Basic Information
10.3.2 Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
10.3.3 Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Market Performance
10.3.4 Inc. Age-Related Macular Degeneration (AMD) Therapeutics SWOT Analysis
10.3.5 Inc. Business Overview
10.3.6 Inc. Recent Developments
10.4 F. Hoffmann-La Roche Ltd.
10.4.1 F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Basic Information
10.4.2 F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
10.4.3 F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Product Market Performance
10.4.4 F. Hoffmann-La Roche Ltd. Business Overview
10.4.5 F. Hoffmann-La Roche Ltd. Recent Developments
10.5 Novartis AG
10.5.1 Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Basic Information
10.5.2 Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
10.5.3 Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Product Market Performance
10.5.4 Novartis AG Business Overview
10.5.5 Novartis AG Recent Developments
10.6 Regeneron Pharmaceuticals Inc.
10.6.1 Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Basic Information
10.6.2 Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
10.6.3 Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Market Performance
10.6.4 Regeneron Pharmaceuticals Inc. Business Overview
10.6.5 Regeneron Pharmaceuticals Inc. Recent Developments
11 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast
11.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Region
11.2.4 South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Age-Related Macular Degeneration (AMD) Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Age-Related Macular Degeneration (AMD) Therapeutics by Type (2025-2032)
12.1.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Age-Related Macular Degeneration (AMD) Therapeutics by Type (2025-2032)
12.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast by Application (2025-2032)
12.2.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) Forecast by Application
12.2.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Age-Related Macular Degeneration (AMD) Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age-Related Macular Degeneration (AMD) Therapeutics as of 2022)
Table 10. Global Market Age-Related Macular Degeneration (AMD) Therapeutics Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Age-Related Macular Degeneration (AMD) Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Age-Related Macular Degeneration (AMD) Therapeutics Product Type
Table 13. Global Age-Related Macular Degeneration (AMD) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Age-Related Macular Degeneration (AMD) Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Age-Related Macular Degeneration (AMD) Therapeutics Market Challenges
Table 22. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Type (K MT)
Table 23. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (M USD)
Table 24. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) by Type (2019-2024)
Table 25. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Age-Related Macular Degeneration (AMD) Therapeutics Price (USD/MT) by Type (2019-2024)
Table 29. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) by Application
Table 30. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application
Table 31. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Application (2019-2024) & (K MT)
Table 32. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2019-2024)
Table 35. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region (2019-2024) & (K MT)
Table 37. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Age-Related Macular Degeneration (AMD) Therapeutics Sales by Country (2019-2024) & (K MT)
Table 39. Europe Age-Related Macular Degeneration (AMD) Therapeutics Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region (2019-2024) & (K MT)
Table 41. South America Age-Related Macular Degeneration (AMD) Therapeutics Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region (2019-2024) & (K MT)
Table 43. Global Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT) by Region (2019-2024)
Table 44. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Region (2019-2024)
Table 46. Global Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Basic Information
Table 52. Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
Table 53. Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Amgen Inc. Business Overview
Table 55. Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics SWOT Analysis
Table 56. Amgen Inc. Recent Developments
Table 57. Bausch Health Companies Age-Related Macular Degeneration (AMD) Therapeutics Basic Information
Table 58. Bausch Health Companies Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
Table 59. Bausch Health Companies Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Bausch Health Companies Business Overview
Table 61. Bausch Health Companies Age-Related Macular Degeneration (AMD) Therapeutics SWOT Analysis
Table 62. Bausch Health Companies Recent Developments
Table 63. Inc. Age-Related Macular Degeneration (AMD) Therapeutics Basic Information
Table 64. Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
Table 65. Inc. Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Inc. Age-Related Macular Degeneration (AMD) Therapeutics SWOT Analysis
Table 67. Inc. Business Overview
Table 68. Inc. Recent Developments
Table 69. F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Basic Information
Table 70. F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
Table 71. F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. F. Hoffmann-La Roche Ltd. Business Overview
Table 73. F. Hoffmann-La Roche Ltd. Recent Developments
Table 74. Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Basic Information
Table 75. Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
Table 76. Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Novartis AG Business Overview
Table 78. Novartis AG Recent Developments
Table 79. Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Basic Information
Table 80. Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
Table 81. Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Regeneron Pharmaceuticals Inc. Business Overview
Table 83. Regeneron Pharmaceuticals Inc. Recent Developments
Table 84. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Region (2025-2032) & (K MT)
Table 85. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Region (2025-2032) & (M USD)
Table 86. North America Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Country (2025-2032) & (K MT)
Table 87. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 88. Europe Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Country (2025-2032) & (K MT)
Table 89. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 90. Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Region (2025-2032) & (K MT)
Table 91. Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Region (2025-2032) & (M USD)
Table 92. South America Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Country (2025-2032) & (K MT)
Table 93. South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 94. Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Consumption Forecast by Country (2025-2032) & (Units)
Table 95. Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 96. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Type (2025-2032) & (K MT)
Table 97. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Type (2025-2032) & (M USD)
Table 98. Global Age-Related Macular Degeneration (AMD) Therapeutics Price Forecast by Type (2025-2032) & (USD/MT)
Table 99. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) Forecast by Application (2025-2032)
Table 100. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Age-Related Macular Degeneration (AMD) Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age-Related Macular Degeneration (AMD) Therapeutics as of 2022)
Table 10. Global Market Age-Related Macular Degeneration (AMD) Therapeutics Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Age-Related Macular Degeneration (AMD) Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Age-Related Macular Degeneration (AMD) Therapeutics Product Type
Table 13. Global Age-Related Macular Degeneration (AMD) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Age-Related Macular Degeneration (AMD) Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Age-Related Macular Degeneration (AMD) Therapeutics Market Challenges
Table 22. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Type (K MT)
Table 23. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (M USD)
Table 24. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) by Type (2019-2024)
Table 25. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Age-Related Macular Degeneration (AMD) Therapeutics Price (USD/MT) by Type (2019-2024)
Table 29. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) by Application
Table 30. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application
Table 31. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Application (2019-2024) & (K MT)
Table 32. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2019-2024)
Table 35. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region (2019-2024) & (K MT)
Table 37. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Age-Related Macular Degeneration (AMD) Therapeutics Sales by Country (2019-2024) & (K MT)
Table 39. Europe Age-Related Macular Degeneration (AMD) Therapeutics Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region (2019-2024) & (K MT)
Table 41. South America Age-Related Macular Degeneration (AMD) Therapeutics Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region (2019-2024) & (K MT)
Table 43. Global Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT) by Region (2019-2024)
Table 44. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Region (2019-2024)
Table 46. Global Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Basic Information
Table 52. Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
Table 53. Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Amgen Inc. Business Overview
Table 55. Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics SWOT Analysis
Table 56. Amgen Inc. Recent Developments
Table 57. Bausch Health Companies Age-Related Macular Degeneration (AMD) Therapeutics Basic Information
Table 58. Bausch Health Companies Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
Table 59. Bausch Health Companies Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Bausch Health Companies Business Overview
Table 61. Bausch Health Companies Age-Related Macular Degeneration (AMD) Therapeutics SWOT Analysis
Table 62. Bausch Health Companies Recent Developments
Table 63. Inc. Age-Related Macular Degeneration (AMD) Therapeutics Basic Information
Table 64. Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
Table 65. Inc. Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Inc. Age-Related Macular Degeneration (AMD) Therapeutics SWOT Analysis
Table 67. Inc. Business Overview
Table 68. Inc. Recent Developments
Table 69. F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Basic Information
Table 70. F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
Table 71. F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. F. Hoffmann-La Roche Ltd. Business Overview
Table 73. F. Hoffmann-La Roche Ltd. Recent Developments
Table 74. Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Basic Information
Table 75. Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
Table 76. Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Novartis AG Business Overview
Table 78. Novartis AG Recent Developments
Table 79. Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Basic Information
Table 80. Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
Table 81. Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Regeneron Pharmaceuticals Inc. Business Overview
Table 83. Regeneron Pharmaceuticals Inc. Recent Developments
Table 84. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Region (2025-2032) & (K MT)
Table 85. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Region (2025-2032) & (M USD)
Table 86. North America Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Country (2025-2032) & (K MT)
Table 87. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 88. Europe Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Country (2025-2032) & (K MT)
Table 89. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 90. Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Region (2025-2032) & (K MT)
Table 91. Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Region (2025-2032) & (M USD)
Table 92. South America Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Country (2025-2032) & (K MT)
Table 93. South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 94. Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Consumption Forecast by Country (2025-2032) & (Units)
Table 95. Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 96. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Type (2025-2032) & (K MT)
Table 97. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Type (2025-2032) & (M USD)
Table 98. Global Age-Related Macular Degeneration (AMD) Therapeutics Price Forecast by Type (2025-2032) & (USD/MT)
Table 99. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) Forecast by Application (2025-2032)
Table 100. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Age-Related Macular Degeneration (AMD) Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (M USD), 2019-2032
Figure 5. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (M USD) (2019-2032)
Figure 6. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (M USD)
Figure 11. Age-Related Macular Degeneration (AMD) Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Age-Related Macular Degeneration (AMD) Therapeutics Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Age-Related Macular Degeneration (AMD) Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type
Figure 18. Sales Market Share of Age-Related Macular Degeneration (AMD) Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Age-Related Macular Degeneration (AMD) Therapeutics by Type in 2023
Figure 20. Market Size Share of Age-Related Macular Degeneration (AMD) Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Age-Related Macular Degeneration (AMD) Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application
Figure 24. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application in 2023
Figure 28. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Age-Related Macular Degeneration (AMD) Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Region in 2023
Figure 44. China Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (K MT)
Figure 50. South America Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Age-Related Macular Degeneration (AMD) Therapeutics Production Market Share by Region (2019-2024)
Figure 62. North America Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 65. China Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share Forecast by Type (2025-2032)
Figure 70. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Application (2025-2032)
Figure 71. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Age-Related Macular Degeneration (AMD) Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (M USD), 2019-2032
Figure 5. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (M USD) (2019-2032)
Figure 6. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (M USD)
Figure 11. Age-Related Macular Degeneration (AMD) Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Age-Related Macular Degeneration (AMD) Therapeutics Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Age-Related Macular Degeneration (AMD) Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type
Figure 18. Sales Market Share of Age-Related Macular Degeneration (AMD) Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Age-Related Macular Degeneration (AMD) Therapeutics by Type in 2023
Figure 20. Market Size Share of Age-Related Macular Degeneration (AMD) Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Age-Related Macular Degeneration (AMD) Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application
Figure 24. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application in 2023
Figure 28. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Age-Related Macular Degeneration (AMD) Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Region in 2023
Figure 44. China Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (K MT)
Figure 50. South America Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Age-Related Macular Degeneration (AMD) Therapeutics Production Market Share by Region (2019-2024)
Figure 62. North America Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 65. China Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share Forecast by Type (2025-2032)
Figure 70. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Application (2025-2032)
Figure 71. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share Forecast by Application (2025-2032)
